Rigel Pharmaceuticals, Inc.

NASDAQ:RIGL

16.44 (USD) • At close December 24, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999
Revenue 116.882120.242149.236108.62159.28844.5094.48420.38328.8958.257.152.254.751250.75012.633.47316.5264.73311.05515.78815.30313.2188.984
Cost of Revenue 7.111.7491.0830.8950.9060.28746.26963.44662.82567.69675.32878.77800000000000-7.557-1.906
Gross Profit 109.772118.493148.153107.72658.38244.222-41.785-43.063-33.93-59.446-68.178-76.5284.751250.75012.633.47316.5264.73311.05515.78815.30320.77510.89
Gross Profit Ratio 0.9390.9850.9930.9920.9850.994-9.319-2.113-1.174-7.206-9.535-34.012111011111111.5721.212
Reseach & Development Expenses 24.52260.27265.23760.10152.88546.90346.26963.44662.82567.69675.32878.77869.3564.39290.743109.6770.36456.96852.03848.52343.36343.3532.31332.03417.112
General & Administrative Expenses 0000070.00237.83120.90817.81331.80319.61222.84921.76825.29120.90327.04421.76319.55212.4113.0778.5199.4547.956.6890
Selling & Marketing Expenses 0000000000000000000000000
SG&A 105.741112.45191.89176.59874.58870.00237.83120.90817.81331.80319.61222.84921.76825.29120.90327.04421.76319.55212.4113.0778.5199.4547.956.6893.952
Other Expenses 01.323.521000000000000000000007.5571.906
Operating Expenses 130.263172.723157.128136.699127.473116.90584.184.35480.63899.49994.94101.62791.11889.683111.646136.71492.12776.5264.44861.651.88252.80440.26346.2822.97
Operating Income -20.491-54.23-8.975-28.973-69.091-72.683-79.616-69.741-51.743-91.249-89.469-99.377-86.36835.317-112.037-136.714-79.527-43.047-47.922-56.867-40.827-37.016-24.96-25.505-12.08
Operating Income Ratio -0.175-0.451-0.06-0.267-1.165-1.633-17.756-3.422-1.791-11.06-12.513-44.168-18.1830.283-149.3830-6.312-1.286-2.9-12.015-3.693-2.345-1.631-1.93-1.345
Total Other Income Expenses Net -4.6-3.023-4.813-0.7712.1972.2031.6240.5250.2790.3410.4420.5370.3952.5730.3974.2795.2555.412.6660.612-0.37-0.0141.1550.1450
Income Before Tax -25.091-58.573-17.309-29.744-66.894-70.48-77.992-69.216-51.464-90.908-89.027-98.84-85.97337.89-111.64-132.435-74.272-37.637-45.256-56.255-41.197-37.03-23.805-25.360
Income Before Tax Ratio -0.215-0.487-0.116-0.274-1.128-1.583-17.393-3.396-1.781-11.019-12.451-43.929-18.10.303-148.8530-5.895-1.124-2.738-11.886-3.727-2.345-1.556-1.9190
Income Tax Expense 03.0230.6050.647-0.3482.203-2.0894.304-1.718-2.70-2.4330.420.091-0.093-0.089000-0.6120.370000.286
Net Income -25.091-61.596-17.914-30.391-66.546-70.48-77.992-69.216-51.464-90.908-89.027-98.84-85.97337.89-111.547-132.346-74.272-37.637-45.256-56.255-41.197-37.03-23.805-25.36-12.366
Net Income Ratio -0.215-0.512-0.12-0.28-1.122-1.583-17.393-3.396-1.781-11.019-12.451-43.929-18.10.303-148.7290-5.895-1.124-2.738-11.886-3.727-2.345-1.556-1.919-1.376
EPS -1.44-3.4-1.05-1.76-4-4.39-6.17-7.33-5.82-10.37-10.2-1.32-1.360.73-2.73-3.67-2.57-1.51-2.07-3.12-3.62-66.73-5.75-31.43-355.49
EPS Diluted -1.44-3.4-1.05-1.76-4-4.39-6.17-7.33-5.82-10.37-10.2-1.32-1.360.72-2.73-3.67-2.57-1.51-2.07-3.12-3.62-66.73-5.75-31.43-355.49
EBITDA -16.981-53.868-11.287-27.685-65.876-69.886-77.527-63.03-50.304-88.89-85.198-96.944-83.99339.298-110.034-130.85-79.527-43.047-47.922-54.494-37.65-31.192-18.2-17.948-10.174
EBITDA Ratio -0.145-0.445-0.06-0.261-1.123-1.633-17.919-2.86-1.793-11.072-11.854-44.168-17.6830.295-145.1910-6.205-1.244-2.828-11.507-3.39-1.976-1.189-1.358-1.132